INmune Bio Inc. (INMB)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
INMB price, last 12 months
Key stats
- Previous close
- $1.03
- Open
- $1.03
- Day range
- $0.8901 – $1.03
- 52-week range
- $0.8104 – $2.60
- Volume
- 418.9K
- Avg volume (20 days)
- 372.5K
- Market cap
- $32.5M
Performance
Technicals and fundamentals
About INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $32.5M